Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus

Ann Rheum Dis. 2022 May;81(5):e75. doi: 10.1136/annrheumdis-2020-217728. Epub 2020 May 20.

Chia-Ying Wu^#¹, Magdalene Tan¹, Jing-Yang Huang^#^{2

3}, Jeng-Yuan Chiou⁴, James Cheng-Chung Wei^{5

6}

¹ School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
² Department of Medical Research, Chung Shan Medical University Hospital, Taichung City, Taiwan.
³ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
⁴ School of Health Policy and Management, Chung Shan Medical University, Taichung, Taiwan.
⁵ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan wei3228@gmail.com.
⁶ Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.

^# Contributed equally.

No abstract available

Keywords: epidemiology; hydroxychloroquine; lupus Nephritis; lupus erythematosus; systemic.

Publication types